KEYZELL
Biopharmaceutical company in clinical stage focused on the development of targeted anticancer compounds.
KEYZELL
Industry:
Biotechnology Health Diagnostics Product Research
Address:
Seville, Andalucia, Spain
Country:
Spain
Website Url:
http://www.keyzell.com
Status:
Active
Similar Organizations
Biopromic
Biopromic is a medical device company specializing in the development of rapid point-of-care diagnostics and ultrasensitive.
Novaptech
Novaptech is a evelops aptamer-based tools in the frame of technology transfer and innovation project Company.
VitrOmics Healthcare Holding BV
VitrOmics Healthcare Holding BV is focusing on the development of new diagnostic products.
Official Site Inspections
http://www.keyzell.com Semrush global rank: 6.39 M Semrush visits lastest month: 1.06 K
- Host name: ns70341.webempresa.eu
- IP address: 5.196.173.71
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
More informations about "KeyZell"
About KeyZell - Keyzell
KeyZell is a biotechnology company developing digital cancer treatments and tools.. KeyZell has an experienced management team with great success stories in the management of large โฆSee details»
Company - Keyzell
KeyZell is a biotechnology company that is in the development phase of digital cancer treatments and tools. see more. Investigator Dr. Nabil Hajji is a world-renowned expert in the field of โฆSee details»
KeyZell - Crunchbase Company Profile & Funding
KeyZell is a biotechnology company that offers oncology solutions based on precision medicine that improves the lives of patients. ... Chrome Extension. Solutions. Products. Resources. โฆSee details»
KeyZell - LinkedIn
KeyZell is a Spanish startup that has managed to combine biotechnology with mathematics and develop in a pioneering manner artificial intelligence systems for the diagnosis and treatment โฆSee details»
KeyZell Company Profile 2024: Valuation, Funding & Investors
KeyZell General Information Description. Operator of a biotechnology company focused on the discovery and development of a new generation of anticancer drugs. The company's platform โฆSee details»
KeyZell - Products, Competitors, Financials, Employees, โฆ
KeyZell's main offerings include a first-line treatment for certain types of tumors that targets cancer cells and prevents metastasis, as well as an AI-based system, the O.P.S. (oncology โฆSee details»
KEYZELL | AseBio - Asociación Empresas Biotecnología
KeyZell is a bio-pharmaceutical company established in 2020 with subsidiaries in the United Kingdom, Australia, Thailand, and Mexico. Our primary goal is to bring a frontline molecule to โฆSee details»
KeyZell - Sevilla, Spain
Mar 22, 2022 KeyZell is a pioneering biotechnology company focused on the discovery and development of a new generation of cancer drugs, as well as an innovative artificial โฆSee details»
Management team - Keyzell
He has worked in Spain, South Africa, and Morocco, excelling in sectors such as automotive, metal, and renewable energy. As CEO of KeyZell, he spearheads the development of โฆSee details»
KeyZell - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 10, 2024 Organization. KeyZell . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 18. Monthly Visits 180. โฆSee details»
#NewAseBioMember | โAseBio is a pivotal networking platform for ...
May 23, 2024 At KeyZell, we go beyond developing innovative drugs. We have also created two advanced artificial intelligence systems: the Oncology Precision System (O.P.S.), a disruptive โฆSee details»
KeyZell start-up plans to reach 5 million euros in private โฆ
MADRID, March 17, 2022 /PRNewswire/ -- KeyZell, a Spanish biotechnology company in the development phase of digital cancer treatments and tools, h...See details»
Investors - Keyzell
This market is led by the US. In the US, it has a 42% share, followed by the top five European markets: Germany, France, Great Britain, Italy and Spain. Today, KeyZell is going to start a โฆSee details»
KeyZell start-up plans to reach 5 million euros in private โฆ
Mar 17, 2022 KeyZell launches this new round of private investment to conduct a human clinical trial with one of its innovative cancer treatments, based on Dr. Nabil Hajji's research on cellular โฆSee details»
KeyZell start-up plans to reach 5 million euros in private
MADRID, March 17, 2022 /PRNewswire/ -- KeyZell, a Spanish biotechnology company in the development phase of digital cancer treatments and tools, has just opened a private financing โฆSee details»
VivaWell and Keyzell Holding Announce Strategic Global โฆ
Aug 6, 2024 Keyzell Holding is currently leading this biomedical revolution in precision medicine worldwide. Recently awarded with โ Premio Andalucía Excellence 2022 โ in Biotechnology.See details»
KeyZell start-up plans to reach 5 million euros in private โฆ
Mar 22, 2022 KeyZell, a Spanish biotechnology start-up in the development phase of digital cancer treatments and tools, has just opened a private financing round which expects to โฆSee details»
Contact - Keyzell
Contact Let us help you Contact us Management [email protected] Contact [email protected] Communication [email protected] HR [email protected] โฆSee details»
VivaWell and Keyzell Holding Announce Strategic Global โฆ
Aug 6, 2024 Keyzell Holding is currently leading this biomedical revolution in precision medicine worldwide. Recently awarded with "Premio Andalucía Excellence 2022" in Biotechnology. The โฆSee details»